BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29264392)

  • 1.
    Hector RD; Kalscheuer VM; Hennig F; Leonard H; Downs J; Clarke A; Benke TA; Armstrong J; Pineda M; Bailey MES; Cobb SR
    Neurol Genet; 2017 Dec; 3(6):e200. PubMed ID: 29264392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not Just Loss-of-Function Variations: Identification of a Hypermorphic Variant in a Patient With a CDKL5 Missense Substitution.
    Frasca A; Pavlidou E; Bizzotto M; Gao Y; Balestra D; Pinotti M; Dahl HA; Mazarakis ND; Landsberger N; Kinali M
    Neurol Genet; 2022 Apr; 8(2):e666. PubMed ID: 35280940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of Cdkl5 transcript isoforms in rat.
    Hector RD; Dando O; Ritakari TE; Kind PC; Bailey ME; Cobb SR
    Gene; 2017 Mar; 603():21-26. PubMed ID: 27940108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanding the phenotype of the CDKL5 deficiency disorder: Are seizures mandatory?
    MacKay CI; Bick D; Prokop JW; Muñoz I; Rouse J; Downs J; Leonard H
    Am J Med Genet A; 2020 May; 182(5):1217-1222. PubMed ID: 32034940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring genotype-phenotype relationships in the CDKL5 deficiency disorder using an international dataset.
    MacKay CI; Wong K; Demarest ST; Benke TA; Downs J; Leonard H
    Clin Genet; 2021 Jan; 99(1):157-165. PubMed ID: 33047306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterisation of CDKL5 Transcript Isoforms in Human and Mouse.
    Hector RD; Dando O; Landsberger N; Kilstrup-Nielsen C; Kind PC; Bailey ME; Cobb SR
    PLoS One; 2016; 11(6):e0157758. PubMed ID: 27315173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two Novel Variants Affecting CDKL5 Transcript Associated with Epileptic Encephalopathy.
    Neupauerová J; Štěrbová K; Vlčková M; Sebroňová V; Maříková T; Krůtová M; David S; Kršek P; Žaliová M; Seeman P; Laššuthová P
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):613-618. PubMed ID: 28872899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDKL5 deficiency disorder in males: Five new variants and review of the literature.
    Siri B; Varesio C; Freri E; Darra F; Gana S; Mei D; Porta F; Fontana E; Galati G; Solazzi R; Niceta M; Veggiotti P; Alfei E
    Eur J Paediatr Neurol; 2021 Jul; 33():9-20. PubMed ID: 33989939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive In Silico Functional Prediction Analysis of CDKL5 by Single Amino Acid Substitution in the Catalytic Domain.
    Yoshimura Y; Morii A; Fujino Y; Nagase M; Kitano A; Ueno S; Takeuchi K; Yamashita R; Inazu T
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel C-terminal truncated mutation in hCDKL5 protein causing a severe West syndrome: Comparison with previous truncated mutations and genotype/phenotype correlation.
    Jdila MB; Triki C; Rhouma BB; Jomaa RB; Issa AB; Ammar-Keskes L; Kamoun F; Fakhfakh F
    Int J Dev Neurosci; 2019 Feb; 72():22-30. PubMed ID: 30236769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel transcript of cyclin-dependent kinase-like 5 (CDKL5) has an alternative C-terminus and is the predominant transcript in brain.
    Williamson SL; Giudici L; Kilstrup-Nielsen C; Gold W; Pelka GJ; Tam PP; Grimm A; Prodi D; Landsberger N; Christodoulou J
    Hum Genet; 2012 Feb; 131(2):187-200. PubMed ID: 21748340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splicing Mutations Impairing CDKL5 Expression and Activity Can be Efficiently Rescued by U1snRNA-Based Therapy.
    Balestra D; Giorgio D; Bizzotto M; Fazzari M; Ben Zeev B; Pinotti M; Landsberger N; Frasca A
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal origin of a novel C-terminal truncation mutation in CDKL5 causing a severe atypical form of Rett syndrome.
    Nectoux J; Heron D; Tallot M; Chelly J; Bienvenu T
    Clin Genet; 2006 Jul; 70(1):29-33. PubMed ID: 16813600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vagus nerve stimulation for the treatment of refractory epilepsy in the CDKL5 Deficiency Disorder.
    Lim Z; Wong K; Downs J; Bebbington K; Demarest S; Leonard H
    Epilepsy Res; 2018 Oct; 146():36-40. PubMed ID: 30071384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel mutations in cyclin-dependent kinase-like 5 (CDKL5) gene in Indian cases of Rett syndrome.
    Das DK; Mehta B; Menon SR; Raha S; Udani V
    Neuromolecular Med; 2013 Mar; 15(1):218-25. PubMed ID: 23242510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and gene mutational spectrum of CDKL5-related diseases in a cohort of Chinese patients.
    Zhao Y; Zhang X; Bao X; Zhang Q; Zhang J; Cao G; Zhang J; Li J; Wei L; Pan H; Wu X
    BMC Med Genet; 2014 Feb; 15():24. PubMed ID: 24564546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKL5-Related Disorders: From Clinical Description to Molecular Genetics.
    Bahi-Buisson N; Bienvenu T
    Mol Syndromol; 2012 Apr; 2(3-5):137-152. PubMed ID: 22670135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-silico Analysis of
    Accetturo M; Bartolomeo N; Stella A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979111
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients.
    Lim Z; Wong K; Olson HE; Bergin AM; Downs J; Leonard H
    Epilepsia; 2017 Aug; 58(8):1415-1422. PubMed ID: 28605011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison and optimization of in silico algorithms for predicting the pathogenicity of sodium channel variants in epilepsy.
    Holland KD; Bouley TM; Horn PS
    Epilepsia; 2017 Jul; 58(7):1190-1198. PubMed ID: 28518218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.